Lithium induced myeloradiculopathy - A rare case report of serious SILENT phenomenon.

Abstract

Lithium is well recognized mood stabilizer and state of the art treatment for bipolar affective disorder. Monitoring serum levels of lithium is recommended for long-term lithium prophylaxis. There are reports of lithium induced neurotoxicity at therapeutic doses. We describe a case report of a lady with bipolar affective disorder who was maintaining well for 4 years on lithium and sub-acutely developed myeloradiculopathy for which extensive work up revealed normal serum lithium with reduced vitamin B12 and Folate.